Keywords: Vectura, Seebri Breezhaler, Novartis, Edison Investment Research, QVA149

Positive outlook for Vectura, as Seebri Breezhaler closer to EU approval

Article | 02 August 2012

Print This

UK-based inhalation product development company Vectura (LSE: VEC) is a step closer to European approval and launch of its once-daily ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in